Why prescription drug prices are falling in 2026
If you’re asking why are prescription drug prices falling 2026, the short answer is Medicare negotiation, manufacturer discount deals, and generic competition. On August 12, 2026, the Bureau of Labor Statistics reported that prescription drug prices fell 3.1% over the past year—the steepest annual drop since March 1963 BLS CPI release. For a family paying $500 a month on maintenance meds, that’s roughly $186 a year back in your pocket before you even change how you shop.
How This Was Verified
This post is based on the BLS July 2026 CPI release (August 12, 2026), CMS’s negotiated-prices infographic for Medicare Part D, the White House TrumpRx launch release, Senator Warren’s August 13, 2026 letter to HHS, and the spring 2026 KFF Health Tracking Poll, plus reporting from Axios, USA Today, NPR, and 46brooklyn. We verified dates, percentages, drug names, and discount ranges against primary documents. We could not independently confirm the TrumpRx $700M savings claim (White House) because deal terms are unreleased, nor the durability of Most Favored Nation deals, which HHS admitted expire at the end of the current presidential term. Last verified: August 2026.
Prescription drug prices just had their biggest drop in 60 years
Yes—prescription drug prices fell 0.8% in July 2026 and 3.1% year-over-year, the steepest annual decline since March 1963 BLS CPI release. Medical care commodities fell 2.7% year-over-year, while hospital services rose 5.2% and overall CPI rose 3.4% BLS CPI table. Notably, there have been zero monthly price increases in 2026, with seven straight declines since December 2025 Axios.
Why are prescription drug prices falling in 2026?
Prices are falling because Medicare’s first negotiated drug prices took effect January 1, 2026, cutting costs up to 79% below list, while GLP-1 cash-pay competition and generics (about 90% of all fills) pushed the index down CMS infographic. Here are the four main drivers:
1. Medicare IRA negotiation. Round 1 covers 10 Part D drugs, including Eliquis, Jardiance, Xarelto, and NovoLog, with negotiated prices up to 79% below list since January 2026 USA Today.
2. GLP-1 competition. Manufacturer cash-pay deals dropped Ozempic from $1,028 to an average of $350, with prices as low as $199 per month; Wegovy pill is $149, and Zepbound averages $346 White House release.
3. Generics. Roughly 90% of US prescriptions are filled with generics, and that competition is the primary downward force on prices USA Today.
4. TrumpRx cash-pay tool. Launched February 5, 2026, it lists about 80 medications at up to 95% off list, though it doesn’t sell drugs or process insurance TrumpRx.
The credit fight. USC economist Geoffrey Joyce says TrumpRx “often points consumers to prices that already exist,” and adds, “If you were going to give policy credit, you’d have to say the IRA.” BLS also confirmed that manufacturer rebates paid after the transaction aren’t captured in the index, meaning some real savings aren’t even counted Axios.
The catch: why your copay may not drop
List-price declines don’t automatically lower your copay because insurers and PBMs set your cost-sharing separately. In the first two weeks of January 2026, 872 brand drugs raised list prices by a median of 4%, and all 16 companies that signed TrumpRx deals still raised some 2026 list prices NPR. Spring 2026 KFF polling found 59% of adults worry about affording prescriptions, 4 in 10 skipped doses or didn’t fill a prescription due to cost, and 42% used a discount card in the past year KFF.
Medicare Part D: savings you can actually bank
Medicare’s negotiated prices are real, contractual, and already saving enrollees money. Round 1, active since January 1, 2026, covers 10 Part D drugs at up to 79% below list, including Eliquis, Jardiance, Xarelto, and NovoLog USA Today. Round 2 adds 15 more drugs effective January 1, 2027, with discounts of 38–85% off 2024 list prices, an estimated $685M in out-of-pocket savings, and 5.3 million enrollees affected CMS infographic. If you’re on Medicare, check whether your drug is on either list. For those exploring GLP-1 options, see our Medicare GLP-1 bridge program cost guide.
| Drug (Round 2) | Discount off 2024 list |
|---|---|
| Janumet | 85% |
| Tradjenta | 84% |
| Breo Ellipta | 83% |
| Linzess | 75% |
| Trelegy | 73% |
| Ozempic/Rybelsus/Wegovy | 71% |
TrumpRx and cash-pay shopping: real savings, narrow lane
TrumpRx is a cash-pay price comparison tool, not a pharmacy and not insurance, that lists about 80 medications at up to 95% off list TrumpRx. Examples include Combigan at $10 versus $204.13 list, Humira Pen at $950 versus $6,922.62, and Ozempic from $199 per month White House release. But skepticism is warranted: Senator Warren’s August 13 letter demands HHS release deal terms by August 27, noting the deals expire at the end of the current presidential term and that RFK Jr. says TrumpRx “does not store any patient, health, or prescription information,” undercutting the $700M savings claim Warren press release. For shopping, compare our roundup of prescription discount cards, our GoodRx review, and Mark Cuban’s Cost Plus Drugs.
5 money moves to capture the drop
Because prescription drug prices fell 3.1% year over year through July 2026, these five moves can turn that decline into lower out-of-pocket costs for you at the pharmacy counter BLS CPI release. Each is specific, actionable, and based on the verified data above.
- Check Medicare negotiation lists. Round 1 is active now; Round 2 hits January 1, 2027. If you’re on Medicare, see if your drug is on either list CMS infographic.
- Compare cash-pay prices before you fill. Check TrumpRx, Cost Plus Drugs, GoodRx, and SingleCare: cash prices can beat your copay, especially for brands TrumpRx.
- Ask your pharmacist about generic alternatives. About 90% of fills are generics USA Today; asking for the generic is one of the fastest ways to cut your cost at the counter.
- Use your HSA strategically. Pay for prescriptions with pre-tax dollars; see our how to maximize your HSA guide.
- Review your marketplace plan formulary for 2027. Formularies change yearly; check coverage before open enrollment using our 2027 ACA marketplace premiums analysis. Also explore our health finance tools to model your costs.
FAQ
Will prescription drug prices keep falling in 2027?
Likely yes, but slower. Round 2 Medicare negotiation takes effect January 1, 2027, with 15 more drugs CMS infographic. The continued decline depends on the generics pipeline and whether TrumpRx MFN deals are extended; they currently expire at the end of the presidential term Warren press release.
Does TrumpRx replace my insurance copay?
No. TrumpRx is a cash-pay price comparison tool; it doesn’t sell drugs and doesn’t process insurance TrumpRx. Use it to find cash prices, then compare against your insurance copay and discount cards, and go with whichever is cheaper.
How do I know if my drug was negotiated by Medicare?
CMS publishes the full list. Round 1 covers 10 drugs active since January 2026 (including Eliquis, Jardiance, Xarelto); Round 2 adds 15 drugs effective January 2027 (including Ozempic, Janumet, Linzess) CMS infographic. Check the list or ask your pharmacist.